Corix Bioscience, Inc.
CXBS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.00 |
|---|---|
| Enterprise Value | $49,667.00 |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | 20,514 |
Return
| Return on Equity | -86.82% |
|---|---|
| Return on Assets | -71.13% |
| Return on Invested Capital | -40.39% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -29.2 |
| Enterprise Value to Net Income | -17 |
| Total Debt to Enterprise | 1.01 |
| Debt to Equity | 14.06 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Corix Bioscience, Inc.
2 employees
CEO: Christ Froese
Corix Bioscience, Inc. specializes in providing cannabidiol (CBD) oil, which is used for various medical applications. The company manages the full cycle of operations, from cultivating and harvesting industrial hemp plants to extracting...